510(k) Report

510(k) · Cleared

Cleared

Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay; Calibrators and Controls

K062242510(k) TraditionalCleared Sep 29, 200658-day reviewClass II21 CFR 862.3610

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lin-Zhi International, Inc. · LAF Gas Chromatography, Methamphetamine

Cleared on Sep 29, 2006 as substantially equivalent to K993208 (OraSure Technologies, Inc., 2000) and 2 other predicates after a 58-day review. Its family tree reaches back 3 generations to 1992. 3 later devices descend from it.

Decided
Sep 29, 2006
Review
58 days
Class
Class II
Product code
LAF
Recalls
None
Predicates
4

Its longest line of descent runs back 3 generations to K924446 (1992). 7 ancestors in all. 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2000: 2 other ancestors1993: 1 other ancestor2014: 1 descendant cleared2021: 1 descendant cleared2015: 1 descendant clearedK924446 · Micro-Plate Opiates Assay · Solarcare Technologies Corp,Inc. · 1992K981341 · STC Opiates Micro-Plate Eia (Orasure Application) · OraSure Technologies, Inc. · 1998K050988 · Opiate Oral Fluid Homogeneous Enzyme Immunoassay, Calibrators and Controls · Lin-Zhi International, Inc. · 20061990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 2 other ancestors 1 generation forward: 1 descendant2 generations forward: 2 descendants K050988 · Opiate Oral Fluid Homogeneous Enzyme Immunoassay, Calibrators and Controls · Lin-Zhi International, Inc. · 2006K981341 · STC Opiates Micro-Plate Eia (Orasure Application) · OraSure Technologies, Inc. · 1998K924446 · Micro-Plate Opiates Assay · Solarcare Technologies Corp,Inc. · 19920
  1. Root · 3 generations backK924446 Micro-Plate Opiates AssaySolarcare Technologies Corp,Inc. · 1992
  2. 2 generations backK981341 STC Opiates Micro-Plate Eia (Orasure Application)OraSure Technologies, Inc. · 1998
  3. 1 generation backK050988 Opiate Oral Fluid Homogeneous Enzyme Immunoassay, Calibrators and…Lin-Zhi International, Inc. · 2006
  4. This deviceK062242 Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay…Lin-Zhi International, Inc. · 2006
  5. Descendant · cites it directly · 2 of its ownK131652 Lzi Oral Fluid Methamphetamine Enzyme Immunoassay, Calibrators…Lin-Zhi International, Inc. · 2014
  6. Descendant · 2 generations on · 0 of its ownK203647 SEFRIA Methamphetamine Oral Fluid Enzyme ImmunoassayImmunalysis Corporation · 2021
  7. Descendant · 2 generations on · 0 of its ownK142293 Rapidfret Oral Fluid Assay for Methamphetamine, Rapidfret Oral Fluid…Biophor Diagnostics, Inc. · 2015

Most influential descendants

Showing 3 of 3 · See all
  • K131652Lzi Oral Fluid Methamphetamine Enzyme Immunoassay, Calibrators, ControlsLin-Zhi International, Inc. · 2014 · cites it directly2descendants
  • K203647SEFRIA Methamphetamine Oral Fluid Enzyme ImmunoassayImmunalysis Corporation · 2021 · 2 generations on0descendants
  • K142293Rapidfret Oral Fluid Assay for Methamphetamine, Rapidfret Oral Fluid Methamphetamine…Biophor Diagnostics, Inc. · 2015 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K924446Micro-Plate Opiates AssaySolarcare Technologies Corp,Inc.1992—
−2K981341STC Opiates Micro-Plate Eia (Orasure Application)OraSure Technologies, Inc.1998—
−1K050988Opiate Oral Fluid Homogeneous Enzyme Immunoassay, Calibrators and ControlsLin-Zhi International, Inc.2006—
0 (this device)K062242Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay; Calibrators and…Lin-Zhi International, Inc.2006—
+1K131652Lzi Oral Fluid Methamphetamine Enzyme Immunoassay, Calibrators, ControlsLin-Zhi International, Inc.2014—
+2K203647SEFRIA Methamphetamine Oral Fluid Enzyme ImmunoassayImmunalysis Corporation2021—
+2K142293Rapidfret Oral Fluid Assay for Methamphetamine, Rapidfret Oral Fluid…Biophor Diagnostics, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
200020
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201510
202110
FIG. 1 — Lineage of K062242, 1992–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LAF device

  1. #1 K203647 SEFRIA Methamphetamine Oral Fluid Enzyme…score 3.8 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
*K993208STC Methamphetamine Intercept Micro-Plate Eia, Model 1104I
Summary page 2
…egally Marketed Predicate Device(s) The LZI Oral Fluid Methamphetamine Enzyme Immunoassay is substantially equivalent to the Methamphetamine Intercept® Micro-plate EIA (K993208) manufactured by OraSure Technologies Inc. (formerly known as STC Technologies, Inc) for its general intended use. The current su…
OraSure Technologies, Inc.20001
Kept off the family treeK050904FDA’s K050904 is Cpap Humidifier, Model HC238JHU
Our reading of the summary gave K050904, FDA’s number for Cpap Humidifier, Model HC238JHU (Fisher & Paykel Healthcare, Ltd.). Its FDA name has none of the distinctive words the summary uses for the device it names, “Oral Fluid Cocaine Homogeneous Enzyme Immunoassay”. Kept off the family tree.
Summary page 2
…s, Inc) for its general intended use. The current subject device is also substantially equivalent to other LZI test systems cleared by FDA, e.g., the Oral Fluid Cocaine (K0509045), Opiate (K050988), and Methadone (K051058) Homogeneous Enzyme Immunoassay for its stated intended use. Device Description LZI…
Fisher & Paykel Healthcare, Ltd.2005—
*K050988Opiate Oral Fluid Homogeneous Enzyme Immunoassay, Calibrators and Controls
Summary page 2
…eral intended use. The current subject device is also substantially equivalent to other LZI test systems cleared by FDA, e.g., the Oral Fluid Cocaine (K0509045), Opiate (K050988), and Methadone (K051058) Homogeneous Enzyme Immunoassay for its stated intended use. Device Description LZI's Oral Fluid Metha…
Lin-Zhi International, Inc.2006—
*K051058Methadone Oral Fluid Homogeneous Enzyme Immunoassay, Calibrators and Controls
Summary page 2
…rrent subject device is also substantially equivalent to other LZI test systems cleared by FDA, e.g., the Oral Fluid Cocaine (K0509045), Opiate (K050988), and Methadone (K051058) Homogeneous Enzyme Immunoassay for its stated intended use. Device Description LZI's Oral Fluid Methamphetamine Enzyme Immunoa…
Lin-Zhi International, Inc.2006—

Also cleared against K993208: 2 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K131652Lzi Oral Fluid Methamphetamine Enzyme Immunoassay, Calibrators, ControlsLin-Zhi International, Inc.20142

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 5.6 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • Of its descendants, K131652 (Lin-Zhi International, Inc., 2014) has gone furthest, with 2 descendants of its own.
  • 2 other devices also cite its predicate K993208.

How does its category compare?

All LAF devices

LAF Gas Chromatography, Methamphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LAF

2in 2021

2008: 22011: 42012: 22014: 22015: 32016: 12017: 12020: 12021: 2
2007high 4 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LAF

43in 2015

2011: 345 days median2015: 43 days median
2007high 345 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LAF

No recall names LAF since 2007.

Adverse event reports per year · LAF

No MAUDE report names LAF since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—00
20100—00
2011434500
20122—00
20130—00
20142—00
201534300
20161—00
20171—00
20180—00
20190—00
20201—00
20212—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Methamphetamine Enzyme Immunoassays for Drugs of Abuse in Oral Fluid is a homogeneous enzyme immunoassay system to detect methamphetamine in human saliva with a cutoff of 45 ng/mL when testing oral fluid specimen collected with Salivette collector (manufactured by Sarstedt) and diluted with I mL of buffer. The calibtators and controls of the analyte (d-methamphetamine) are prepared with oral fluid buffer so that it can be used to verify and validate…

Read the full statement (164 words)

The Methamphetamine Enzyme Immunoassays for Drugs of Abuse in Oral Fluid is a homogeneous enzyme immunoassay system to detect methamphetamine in human saliva with a cutoff of 45 ng/mL when testing oral fluid specimen collected with Salivette collector (manufactured by Sarstedt) and diluted with I mL of buffer. The calibtators and controls of the analyte (d-methamphetamine) are prepared with oral fluid buffer so that it can be used to verify and validate the assay. The assay is intended for use in the qualitative determination for methamphetamine. The assay is designed for professional use with a number of automated clinical chemistry analyzers.

The Oral Fluid Methamphetamine Enzyme Immunoassay is a homogeneous enzyme immunoassay system provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method Clinical consideration and professional judgment should be applied to any drug-of-abuse test result, particularly when preliminary positive results are used.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062242: Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay; Calibrators and Controls.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062242

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026